reboxetine has been researched along with melatonin in 1 studies
Studies (reboxetine) | Trials (reboxetine) | Recent Studies (post-2010) (reboxetine) | Studies (melatonin) | Trials (melatonin) | Recent Studies (post-2010) (melatonin) |
---|---|---|---|---|---|
626 | 193 | 184 | 23,268 | 1,451 | 9,627 |
Protein | Taxonomy | reboxetine (IC50) | melatonin (IC50) |
---|---|---|---|
Myeloperoxidase | Homo sapiens (human) | 3 | |
Ribosyldihydronicotinamide dehydrogenase [quinone] | Homo sapiens (human) | 3.3323 | |
Metabotropic glutamate receptor 1 | Rattus norvegicus (Norway rat) | 0.0004 | |
Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0005 | |
Melatonin receptor type 1A | Homo sapiens (human) | 0.0025 | |
Melatonin receptor type 1B | Homo sapiens (human) | 0.0035 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Agarwal, SM; Ahsan, ZA; Cohn, T; Duncan, MJ; Faulkner, GEJ; Hahn, M; Lockwood, JT; Remington, G; Stogios, N; Takeuchi, H; Taylor, VH | 1 |
1 review(s) available for reboxetine and melatonin
Article | Year |
---|---|
Pharmacological interventions for prevention of weight gain in people with schizophrenia.
Topics: Antipsychotic Agents; Betahistine; Famotidine; Fluoxetine; Humans; Melatonin; Metformin; Nausea; Nizatidine; Ranitidine; Reboxetine; Schizophrenia; Topiramate; Weight Gain | 2022 |